Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
Dan HenryFoothill Family Clinic, Salt Lake City, Utah, USARobert BettisEdmonds Family Medicine, Edmonds, Washington, USAErnie RifferDaniel HaverstockPharmaceutical Division, Bayer Corporation, West Haven, Connecticut USASteven F. KowalskyPharmaceutical Division, Bayer Corporation, West Haven, Connecticut USAKathryn ManningPharmaceutical Division, Bayer Corporation, West Haven, Connecticut USAKamal HamedPharmaceutical Division, Bayer Corporation, West Haven, Connecticut USADeborah ChurchPharmaceutical Division, Bayer Corporation, West Haven, Connecticut USA
2002en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба